Written by Paige Kane, PhD, CPIP   If you work in Life Sciences, you know that it is a complex, high-stakes operation.  I’ve been through my...

The Windsor Framework (WF), which came into effect on January 1, 2025, is a significant agreement between the UK and the EU that replaces the...

Pharmaceutical companies today face a high-stakes equation: launch faster, meet global demand, and maintain quality and compliance—without fail. That means simultaneously spinning up manufacturing sites,...

Operational readiness is not achieved overnight. It’s developed through deliberate progression across key operational domains. An organization’s readiness maturity reflects how effectively it aligns its...

Operational readiness isn’t a milestone. It’s a condition, a designed state that ensures your facility starts up safely, on time, on budget, and at intended...

THE CASE FOR ESG IN PHARMA Growing Pressure to Focus on Sustainability Pharmaceutical manufacturing has been evolving to meet global demands, while maintaining high quality....

In high-stakes industries where failure isn’t an option, “good enough” simply doesn’t cut it. At CAI, rigor is not just a methodology—it’s our mindset. It’s...

Operational Readiness isn’t just a milestone. It’s a designed condition, one that determines whether your facility can deliver compliant, controlled, and efficient production from Day...

Manufacturing has entered a new era in which success depends on more than traditional optimization methods. While Lean and Six Sigma have served as foundational...